Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001 - Contacts and Locations

Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001

This study is currently recruiting participants.

Study NCT00636090. Last updated on March 13, 2008. Information provided by Duke University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00636090

Contacts


Contact: Karla Morris, BSN	919-668-8375	karla.morris@mc.duke.edu

Locations


United States, North Carolina
	Duke University Medical Center	Recruiting
	Durham, North Carolina, United States, 27710
	Principal Investigator: Daniel George, MD
	Sub-Investigator: Phillip G Febbo, MD

Sponsors and Collaborators

Duke University

Department of Defense

Investigators


Principal Investigator:	Daniel J George, MD	Duke University